Medexus Pharmaceuticals (OTCMKTS:MEDXF) Stock Price Down 5.1% – Here’s What Happened

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) fell 5.1% on Monday . The company traded as low as $2.1365 and last traded at $2.15. 10,700 shares changed hands during mid-day trading, a decline of 11% from the average session volume of 12,037 shares. The stock had previously closed at $2.2660.

Medexus Pharmaceuticals Price Performance

The business’s 50-day simple moving average is $2.17 and its two-hundred day simple moving average is $2.06.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.